BridgeBio Oncology Therapeutics, Inc. (BBOT)

Market Cap	846.35M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	86.45M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	501,178
Open	9.49
Previous Close	9.65
Day's Range	8.73 - 10.35
52-Week Range	8.93 - 10.51
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BBOT

BridgeBio Oncology Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing a pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. The company is based in South San Francisco, California. BridgeBio Oncology Therapeutics, Inc. operates as a subsidiary of BridgeBio Pharma, Inc.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Eli Wallace
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: BBOT
• Website: https://bbotx.com